USE OF NON-PEPTIDIC ANTAGONISTS OF NK1 RECEPTORS FOR THE PRODUCTION OF APOPTOSIS IN TUMOR CELLS.

摘要

The object of the present invention is the use of antagonists of substance P, in particular the use of non-peptide antagonists of NK1 receptors for the treatment of cancer and more specifically on human melanoma, neuroblastoma, glioma, Human Hodgkin lymphoma, lymphoblastic leukemia, human rhabdomyosarcoma, human breast carcinoma, human burkit lymphoma, human lung carcinoma, Edwing's human sarcoma, human glioma and human osteosarcoma.